Sandesh Seth
Chief Executive Officer, Director · Actinium Pharmaceuticals, Inc.
Individual
- 2025
- Sep 4, 2026
- 2
Filings (90d)
Other insiders active in the same sector
No other insider has filed at Sandesh Seth's companies, so these are insiders reporting open-market trades at other companies in the same sector.
- Keith A. Meister - $591.13M in ILMN purchases and sales in the last 12 months
- Ronda E. Stryker - $580.89M in SYK purchases and sales in the last 12 months
- Mozart Aggregator II LP - $579.20M in MDLN purchases and sales in the last 12 months
- TC Group VII S1, L.L.C. - $554.95M in MDLN purchases and sales in the last 12 months
- BERKSHIRE HATHAWAY INC - $473.67M in DVA purchases and sales in the last 12 months
- RA CAPITAL MANAGEMENT, L.P. - $430.69M in PBLS purchases and sales in the last 12 months
More insiders (A-Z)
Browse nearby insider profiles in alphabetical order.
Frequently asked questions
Who is Sandesh Seth?
Sandesh Seth is a corporate insider, tracked as Chief Executive Officer, Director of Actinium Pharmaceuticals, Inc. (ATNM). InsiderAlpha holds 2 primary Form 4 filings for them, the earliest from 2025, updated as new SEC EDGAR filings are processed.
How many SEC Form 4 filings has Sandesh Seth submitted recently?
1 primary Form 4 filing in the last 90 days, covering 1 company.
